Literature DB >> 27524534

Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan.

Abdul Majeed Akhtar1, Muhammad Awais Arif2, Shamsa Kanwal1, Sadia Majeed3.   

Abstract

OBJECTIVE: To determine the prevalence and resistance pattern of multidrug-resistant tuberculosis.
METHODS: This cross-sectional study was carried out from January 2010 to June 2014 in nine tertiary care hospitals implementing programmatic management of drug-resistant tuberculosis in Punjab, and comprised retreatment tuberculosis cases. Data was collected from the Electronic Nominal Review System. SPSS 17 was used for data analysis.
RESULTS: Of the 1,250 cases, 861(69%) were of multidrug-resistant tuberculosis confirmed through drug sensitivity testing. The mean age was 32 (±13.5 SD) years. Besides, 664(53%) were males and 1,208(97%) resided in urban areas of Punjab. Multidrug-resistant tuberculosis was found to be more prevalent in the most productive age group, i.e. 15-45 years, with 709(57%) cases (p<0.05), in urban areas1, 208(97%) cases (p<0.05) and in the pulmonary site 852(68%) cases (p<0.05). Overall, 391(41%) cases showed resistance to all first-line anti-tuberculosis drugs while 239(28%) showed resistance to oral first-line drugs. Besides, 526(42%) cases showed resistance to fluoroquinolones and 650(52%) to second-line drugs. Of them, 420(81%), (p<0.05) patients showed highly significant resistance to fluoroquinolones and 26(5%) to ethionamide.
CONCLUSIONS: There is a need to fully implement national tuberculosis guidelines with a focus on expansion and effective implementation of directly observed therapy short course in order to prevent further emergence of drug resistance.

Entities:  

Keywords:  Multi Drug Resistance, Retreatment Cases, Prevalence, ENRS, PMDT.

Mesh:

Substances:

Year:  2016        PMID: 27524534

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  9 in total

Review 1.  Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective.

Authors:  Emily A Kendall; Ted Cohen; Carole D Mitnick; David W Dowdy
Journal:  Int J Infect Dis       Date:  2016-12-19       Impact factor: 3.623

2.  Epidemiological Characteristics and Risk Factors Related to Drug-resistant Tuberculosis in Luanda, Angola.

Authors:  Cruz S Sebastião; João Samulengo; Euclides Sacomboio; Ngiambudulu M Francisco; Carlos Teixeira; Samuel António; Mizele Kinanga; Zoraima Neto; Joana Paixão; António Mateus; Zinga David; Jocelyne Neto de Vasconcelos; Joana Morais
Journal:  Am J Trop Med Hyg       Date:  2022-01-10       Impact factor: 3.707

3.  Effect of Displacement on Adherence to TB Treatment: An Observational Study in TB Patients from Internally Displaced Persons of Pakistan.

Authors:  Farman Ullah Khan; Zahid Asghar; Muhammad Khalid Tipu; Asim Ur Rehman; Asif Khan; Tofeeq Ur-Rehman
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

4.  Multi-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria.

Authors:  Kome Otokunefor; Tosanwumi V Otokunefor; Godwin Omakwele
Journal:  Afr J Lab Med       Date:  2018-12-06

5.  Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis.

Authors:  Anita Svadzian; Giorgia Sulis; Genevieve Gore; Madhukar Pai; Claudia M Denkinger
Journal:  BMJ Glob Health       Date:  2020-10

6.  Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan.

Authors:  Farman Ullah Khan; Asim Ur Rehman; Faiz Ullah Khan; Khezar Hayat; Amjad Khan; Nafees Ahmad; Jie Chang; Usman Rashid Malik; Yu Fang
Journal:  Int J Environ Res Public Health       Date:  2022-01-29       Impact factor: 3.390

7.  Prevalence of Multi-Drug Resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa - A High Tuberculosis Endemic Area of Pakistan.

Authors:  Sajid Ali; Muhammad Tahir Khan; Anwar Sheed Khan; Noor Mohammad; Muhammad Mumtaz Khan; Sajjad Ahmad; Sadiq Noor; Abdul Jabbar; Cantillon Daire; Fariha Hassan
Journal:  Pol J Microbiol       Date:  2020

8.  Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.

Authors:  Saba Kabir; Zarfishan Tahir; Nadia Mukhtar; Muhammad Sohail; Muhammad Saqalein; Abdul Rehman
Journal:  BMC Pulm Med       Date:  2020-05-11       Impact factor: 3.317

9.  Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014-2017.

Authors:  F Iqbal; M K Defer; A Latif; H Hadi
Journal:  Epidemiol Infect       Date:  2020-09-30       Impact factor: 2.451

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.